South Dakota Investment Council’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
Other funds holding RGLS
BI
NMC
WS
PAM
South Dakota Investment Council's RGLS Position: Q4 2018 in Review
South Dakota Investment Council sold out of Regulus Therapeutics (RGLS) in Q4 2018, closing a stake of 3,064 shares — an estimated $73K sold.
South Dakota Investment Council first reported a position in RGLS in Q1 2015 and held it in 15 quarters. The position peaked at $2.97M in Q3 2016. 27 funds tracked by Wall St. Rank hold RGLS as of Q4 2018.
- South Dakota Investment Council reported no remaining Regulus Therapeutics position as of Q4 2018 after selling out during the quarter.
- South Dakota Investment Council sold 3,064 Regulus Therapeutics shares in Q4 2018, an estimated $73K.
- South Dakota Investment Council first reported a position in Regulus Therapeutics in Q1 2015 and held it in 15 quarters.
- South Dakota Investment Council's Regulus Therapeutics position peaked at $2.97M in Q3 2016.
- 27 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2018.
Based on South Dakota Investment Council's 13F filing for Q4 2018, filed 6 Feb 2019.